BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25281137)

  • 1. Determination of tamoxifen and its main metabolites in plasma samples from breast cancer patients by micellar liquid chromatography.
    Peris-Vicente J; Ochoa-Aranda E; Bose D; Esteve-Romero J
    Talanta; 2015 Jan; 131():535-40. PubMed ID: 25281137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a methodology to quantify tamoxifen and endoxifen in breast cancer patients by micellar liquid chromatography and validation according to the ICH guidelines.
    Aranda EO; Esteve-Romero J; Rambla-Alegre M; Peris-Vicente J; Bose D
    Talanta; 2011 Apr; 84(2):314-8. PubMed ID: 21376950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen monitoring studies in breast cancer patients by micellar liquid chromatography.
    Esteve-Romero J; Ochoa-Aranda E; Bose D; Rambla-Alegre M; Peris-Vicente J; Martinavarro-Domínguez A
    Anal Bioanal Chem; 2010 Jun; 397(4):1557-61. PubMed ID: 20422162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapy.
    Antunes MV; Raymundo S; de Oliveira V; Staudt DE; Gössling G; Peteffi GP; Biazús JV; Cavalheiro JA; Tre-Hardy M; Capron A; Haufroid V; Wallemacq P; Schwartsmann G; Linden R
    Talanta; 2015 Jan; 132():775-84. PubMed ID: 25476377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of tamoxifen in pharmaceutical formulations using micellar liquid chromatography.
    Peris-Vicente J; Carda-Broch S; Esteve-Romero J
    Anal Sci; 2014; 30(9):925-30. PubMed ID: 25213822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An UPLC-MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers.
    Arellano C; Allal B; Goubaa A; Roché H; Chatelut E
    J Pharm Biomed Anal; 2014 Nov; 100():254-261. PubMed ID: 25173109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive HPLC-PDA determination of tamoxifen and its metabolites N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in human plasma.
    Antunes MV; Rosa DD; Viana Tdos S; Andreolla H; Fontanive TO; Linden R
    J Pharm Biomed Anal; 2013 Mar; 76():13-20. PubMed ID: 23291438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a high-performance liquid chromatography method with fluorescence detection for the routine quantification of tamoxifen, endoxifen and 4-hydroxytamoxifen in plasma from breast cancer patients.
    Rangel-Méndez JA; Graniel-Sabido MJ; Sánchez-Cruz JF; Moo-Puc R
    Biomed Chromatogr; 2019 Apr; 33(4):e4462. PubMed ID: 30536934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
    Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing high-performance liquid chromatography method with fluorescence detection for quantification of tamoxifen and two metabolites in human plasma: application to a clinical study.
    Zhu YB; Zhang Q; Zou JJ; Yu CX; Xiao DW
    J Pharm Biomed Anal; 2008 Jan; 46(2):349-55. PubMed ID: 18037598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method to quantify several tyrosine kinase inhibitors in plasma by micellar liquid chromatography and validation according to the European Medicines Agency guidelines.
    Garrido-Cano I; García-García A; Peris-Vicente J; Ochoa-Aranda E; Esteve-Romero J
    Talanta; 2015 Nov; 144():1287-95. PubMed ID: 26452960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of paroxetine in blood and urine using micellar liquid chromatography with electrochemical detection.
    Agrawal N; Marco-Peiró S; Esteve-Romero J; Durgbanshi A; Bose D; Peris-Vicente J; Carda-Broch S
    J Chromatogr Sci; 2014; 52(10):1217-23. PubMed ID: 24448669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry.
    Binkhorst L; Mathijssen RH; Ghobadi Moghaddam-Helmantel IM; de Bruijn P; van Gelder T; Wiemer EA; Loos WJ
    J Pharm Biomed Anal; 2011 Dec; 56(5):1016-23. PubMed ID: 21872414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in plasma.
    MacCallum J; Cummings J; Dixon JM; Miller WR
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):317-23. PubMed ID: 8738037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatography-mass spectrometry method for the quantification of tamoxifen and its metabolite 4-hydroxytamoxifen in rat plasma: application to interaction study with biochanin A (an isoflavone).
    Singh SP; Wahajuddin ; Ali MM; Kohli K; Jain GK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2845-51. PubMed ID: 21890435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A micellar liquid chromatography method for the quantification of abacavir, lamivudine and raltegravir in plasma.
    Peris-Vicente J; Villareal-Traver M; Casas-Breva I; Carda-Broch S; Esteve-Romero J
    J Pharm Biomed Anal; 2014 Sep; 98():351-5. PubMed ID: 24996008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of selective serotonin reuptake inhibitors in plasma and urine by micellar liquid chromatography coupled to fluorescence detection.
    Agrawal N; Esteve-Romero J; Bose D; Dubey NP; Peris-Vicente J; Carda-Broch S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():142-9. PubMed ID: 25023211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry.
    Gjerde J; Kisanga ER; Hauglid M; Holm PI; Mellgren G; Lien EA
    J Chromatogr A; 2005 Jul; 1082(1):6-14. PubMed ID: 16038189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reductive amination-assisted quantitation of tamoxifen and its metabolites by liquid phase chromatography tandem mass spectrometry.
    Liang SS; Wang TN; Chiu CC; Kuo PL; Huang MF; Liu MC; Tsai EM
    J Chromatogr A; 2016 Feb; 1434():64-9. PubMed ID: 26814364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tamoxifen and metabolites by LC-MS/MS and HPLC methods.
    Heath DD; Flat SW; Wu AH; Pruitt MA; Rock CL
    Br J Biomed Sci; 2014; 71(1):33-9. PubMed ID: 24693573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.